NEUROPACE INC's ticker is NPCE and the CUSIP is 641288105. A total of 33 filers reported holding NEUROPACE INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $130,925 | -27.6% | 17,318 | +26.4% | 0.00% | – |
| Q1 2024 | $180,919 | -45.0% | 13,706 | -57.0% | 0.00% | – |
| Q4 2023 | $328,940 | +514.7% | 31,905 | +480.1% | 0.00% | – |
| Q3 2023 | $53,515 | +116.7% | 5,500 | 0.0% | 0.00% | – |
| Q2 2023 | $24,695 | -59.1% | 5,500 | -57.7% | 0.00% | – |
| Q1 2023 | $60,394 | +211.4% | 13,016 | 0.0% | 0.00% | – |
| Q4 2022 | $19,394 | +177.1% | 13,016 | +620.7% | 0.00% | – |
| Q3 2022 | $7,000 | -56.2% | 1,806 | -43.1% | 0.00% | – |
| Q2 2022 | $16,000 | -57.9% | 3,176 | -30.6% | 0.00% | – |
| Q1 2022 | $38,000 | -44.9% | 4,579 | -33.4% | 0.00% | – |
| Q4 2021 | $69,000 | +50.0% | 6,878 | +136.2% | 0.00% | – |
| Q3 2021 | $46,000 | -4.2% | 2,912 | +43.0% | 0.00% | – |
| Q2 2021 | $48,000 | – | 2,037 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 1,670,136 | $26,472,000 | 4.12% |
| Orbimed Advisors | 4,012,281 | $63,595,000 | 0.70% |
| SECTORAL ASSET MANAGEMENT INC | 444,572 | $7,046,000 | 0.59% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 453,012 | $7,180,000 | 0.11% |
| Bellevue Group AG | 507,930 | $8,051,000 | 0.08% |
| JOHNSON & JOHNSON | 55,435 | $879,000 | 0.08% |
| Nantahala Capital Management | 141,641 | $2,245,000 | 0.07% |
| LORD, ABBETT & CO. LLC | 359,421 | $5,697,000 | 0.01% |
| PICTET ASSET MANAGEMENT SA | 569,875 | $9,033,000 | 0.01% |
| Ghisallo Capital Management LLC | 15,000 | $238,000 | 0.01% |